Polymer-caged nanobins for synergistic cisplatin-doxorubicin combination chemotherapy.
about
Advances in drug delivery system for platinum agents based combination therapyPerspectives of nanotechnology in minimally invasive therapy of breast cancerCo-delivery of 10-hydroxycamptothecin with doxorubicin conjugated prodrugs for enhanced anticancer efficacy.Platinum covalent shell cross-linked micelles designed to deliver doxorubicin for synergistic combination cancer therapyNanocarriers for delivery of platinum anticancer drugs.Nanoparticles with Precise Ratiometric Co-Loading and Co-Delivery of Gemcitabine Monophosphate and Cisplatin for Treatment of Bladder Cancer.DNA Polyplexes as Combinatory Drug Carriers of Doxorubicin and Cisplatin: An in Vitro Study.Combination drug delivery approaches in metastatic breast cancerTumor-targeted polymeric nanostructured lipid carriers with precise ratiometric control over dual-drug loading for combination therapy in non-small-cell lung cancerTargeting tumor microenvironment with PEG-based amphiphilic nanoparticles to overcome chemoresistance.Triggered release of pharmacophores from [Ni(HAsO₃)]-loaded polymer-caged nanobin enhances pro-apoptotic activity: a combined experimental and theoretical study.Hyaluronan-Lysine Cisplatin Drug Carrier for Treatment of Localized Cancers: Pharmacokinetics, Tolerability, and Efficacy in Rodents and Canines.The many spaces of uPAR: delivery of theranostic agents and nanobins to multiple tumor compartments through a single targetArsenite-loaded nanoparticles inhibit PARP-1 to overcome multidrug resistance in hepatocellular carcinoma cellsRecent advances of cocktail chemotherapy by combination drug delivery systems.Tumor microenvironment and nanotherapeutics.Nanoscale particulate systems for multidrug delivery: towards improved combination chemotherapy.Recent advances in biocompatible nanocarriers for delivery of chemotherapeutic cargoes towards cancer therapy.Drug delivery/imaging multifunctionality of mesoporous silica-based composite nanostructures.Programmable nanomedicine: synergistic and sequential drug delivery systems.Target-selective delivery and activation of platinum-based anticancer agents.Polymeric biomaterials for the delivery of platinum-based anticancer drugs.Smart Nanoscale Drug Delivery Platforms from Stimuli-Responsive Polymers and Liposomes.Nanoparticle formulations of cisplatin for cancer therapy.Polymer-lipid hybrid systems: merging the benefits of polymeric and lipid-based nanocarriers to improve oral drug delivery.Targeted hepatocellular carcinoma therapy: transferrin modified, self-assembled polymeric nanomedicine for co-delivery of cisplatin and doxorubicin.Multifunctional platinum-based nanoparticles for biomedical applications.Polysaccharide nano-vesicular multidrug carriers for synergistic killing of cancer cells.Synergistic antitumor effects of doxorubicin-loaded carboxymethyl cellulose nanoparticle in combination with endostar for effective treatment of non-small-cell lung cancer.A targeted theranostic platinum(IV) prodrug containing a luminogen with aggregation-induced emission (AIE) characteristics for in situ monitoring of drug activation.Effect of combined treatment with the epirubicin-incorporating micelles (NC-6300) and 1,2-diaminocyclohexane platinum (II)-incorporating micelles (NC-4016) on a human gastric cancer model.Acid-degradable polymer-caged lipoplex (PCL) platform for siRNA delivery: facile cellular triggered release of siRNACore-shell polymer nanoparticles for prevention of GSH drug detoxification and cisplatin delivery to breast cancer cells.Polydopamine Nanoparticles for Combined Chemo- and Photothermal Cancer Therapy.Shell crosslinked knedel-like nanoparticles for delivery of cisplatin: effects of crosslinking.Toxic Reactive Oxygen Species Enhanced Synergistic Combination Therapy by Self-Assembled Metal-Phenolic Network Nanoparticles.Highly Stable, Ultra-Small Polymer-Grafted Nanobins (usPGNs) with Stimuli-Responsive Capability.Dual Chemodrug-Loaded Single-Walled Carbon Nanohorns for Multimodal Imaging-Guided Chemo-Photothermal Therapy of Tumors and Lung Metastases.Self-Stabilized Hyaluronate Nanogel for Intracellular Codelivery of Doxorubicin and Cisplatin to Osteosarcoma.Dual Chemodrug-Loaded Single-Walled Carbon Nanohorns for Multimodal Imaging-Guided Chemo-Photothermal Therapy of Tumors and Lung Metastases.
P2860
Q26771390-375A4AE1-860F-4CE7-B6A0-A8D14139998FQ26828806-EE836AEE-75FA-4A97-8CCB-C0C886AB25FCQ30590874-4EED496C-7EC0-45E9-874C-69BBD0D9BD7DQ33713159-6FEFFAC6-01DA-4D8F-B1B9-BC6E1AF56393Q34338695-11086956-18E6-4509-A03E-B18CDB1D7E6AQ34479313-91FB5EF8-EBF1-42A5-9788-97CB882BE60EQ35912011-1D3E73AE-2E29-45F9-A1A6-069DA483F25DQ35955198-B5A1354E-966F-4719-AAA8-FDB033523062Q36303474-3AF82B06-7CF7-4176-B5EC-49CF4AFAF15DQ36680180-041E53AB-AF65-489D-BEB6-735DBA757A60Q36831950-407541F8-6E59-4D28-B9BE-D62941843BF4Q36948510-86458835-9AB6-4FA0-8958-4CBACFA2A87EQ36997621-D731A550-D7BC-49B3-BD78-E3C137AE9EFFQ37148048-E1DF70A1-5667-40C6-94E1-9E54DF2C0BB0Q37206908-47CD351F-7596-478F-B291-C6C8C7BA1CD1Q37632757-1A5D872A-3F5B-427C-899F-CF3B35B8C106Q38183852-85E18270-2FD9-42BA-BE34-624C5047C7CCQ38204933-C3991728-B65E-4CD1-BD0C-46511603B4C6Q38205561-9AA77D59-82D9-4011-A4EE-F0245A6DB087Q38336134-879B0BDE-46A7-465B-8A4A-DC86CC842D82Q38523600-B0A063FD-E169-4AFD-BC62-9664688549B5Q38556758-8E921C2D-B2F2-4F62-9484-FA86C066795EQ38626956-323089D3-5DB9-4A7F-B31F-CC7D610B30BCQ38723829-F49C39E9-0BC9-49D4-A46C-277E8E370C23Q38729314-CAB7B2FD-A93A-4F32-A37D-88F28C647C97Q38788994-526C65CB-D230-4BA9-B5BB-A616C802120BQ38812240-EF2E41D7-8225-4EA3-AE73-D3E5ACE1BA8BQ38961730-4C18C0C5-9ACB-4036-B7FF-FA71256F94C0Q38993179-5CF9ACE5-98D2-4D53-911A-A7D2D7EEED6EQ39019063-A2D2FA1A-D6C6-4893-8F70-7128EF8FE328Q39041944-8C33510F-AAF5-4271-85B2-370076248F74Q39100867-FCCAC5A6-7F91-468C-8B12-70565D7DBFDAQ40433843-204915CE-7059-499D-8262-25F9EA56742EQ41175624-44C769A2-140F-4067-85FF-3976D3B1B044Q43602743-3A7943AD-9A39-40AA-B8CC-E7F6880B72F0Q47189597-C1597DDE-CDDB-4DD4-A227-AEEE6902F59CQ49499411-27D7622C-06AB-456E-99D5-BE191EDE1C54Q52647638-578A56FA-7689-47AD-B906-506A33CD9DB2Q55061758-7058A931-1803-465B-AEF5-6A392957CB70Q55076479-6A7CFF20-CF52-4C72-A3A7-22F78C204122
P2860
Polymer-caged nanobins for synergistic cisplatin-doxorubicin combination chemotherapy.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Polymer-caged nanobins for synergistic cisplatin-doxorubicin combination chemotherapy.
@en
Polymer-caged nanobins for synergistic cisplatin-doxorubicin combination chemotherapy.
@nl
type
label
Polymer-caged nanobins for synergistic cisplatin-doxorubicin combination chemotherapy.
@en
Polymer-caged nanobins for synergistic cisplatin-doxorubicin combination chemotherapy.
@nl
prefLabel
Polymer-caged nanobins for synergistic cisplatin-doxorubicin combination chemotherapy.
@en
Polymer-caged nanobins for synergistic cisplatin-doxorubicin combination chemotherapy.
@nl
P2093
P2860
P356
P1476
Polymer-caged nanobins for synergistic cisplatin-doxorubicin combination chemotherapy.
@en
P2093
Sang-Min Lee
SonBinh T Nguyen
Thomas V O'Halloran
P2860
P304
17130-17138
P356
10.1021/JA107333G
P407
P577
2010-11-15T00:00:00Z